BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24059332)

  • 1. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
    Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V
    Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transmissible spongiform encephalopathies of livestock.
    Greenlee JJ; Greenlee MH
    ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prion diseases or transmissible spongiform encephalopathies].
    Brandel JP
    Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
    Sikorska B; Liberski PP
    Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
    Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
    Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics studies on the buffalo prion protein.
    Zhang J; Wang F; Chatterjee S
    J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
    Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
    PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raccoons accumulate PrP
    Moore SJ; Smith JD; Richt JA; Greenlee JJ
    J Vet Diagn Invest; 2019 Mar; 31(2):200-209. PubMed ID: 30694116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
    Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
    Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
    Ayrolles-Torro A; Imberdis T; Torrent J; Toupet K; Baskakov IV; Poncet-Montange G; Grégoire C; Roquet-Baneres F; Lehmann S; Rognan D; Pugnière M; Verdier JM; Perrier V
    J Neurosci; 2011 Oct; 31(42):14882-92. PubMed ID: 22016521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies.
    Hainfellner JA; Budka H
    Acta Neuropathol; 1999 Nov; 98(5):458-60. PubMed ID: 10541867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.